Showing results (731-740 of 843) with videos related to
Sort By:
Pageof 85
AIDS Research and Human Retroviruses|April 20, 2000
Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infectionM L Markert, C B Hicks, J A Bartlett, et al.Journal of Virology|August 11, 2017
HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus MacaquesQifeng Han, Wilton B Williams, Kevin O Saunders, et al.Plos Pathogens|February 25, 2017
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trialDavid Easterhoff, M Anthony Moody, Daniela Fera, et al.Nature|September 5, 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interfaceJinghe Huang, Byong H Kang, Marie Pancera, et al.Plos One|October 3, 2013
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trialRaphael Gottardo, Robert T Bailer, Bette T Korber, et al.Journal of Virology|October 10, 2008
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremiaGeorgia D Tomaras, Nicole L Yates, Pinghuang Liu, et al.The Journal of Experimental Medicine|April 7, 2010
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokinesM Anthony Moody, Hua-Xin Liao, S Munir Alam, et al.Journal of Virology|May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine ResearchLindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.Science Translational Medicine|September 7, 2022
Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infectionKevin O Saunders, Robert J Edwards, Kedamawit Tilahun, et al.Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.Pageof 85